» Articles » PMID: 22474524

Inhibitory Effect of Curcumol on Jak2-STAT Signal Pathway Molecules of Fibroblast-Like Synoviocytes in Patients with Rheumatoid Arthritis

Overview
Date 2012 Apr 5
PMID 22474524
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperplasia of synovial membrane in rheumatoid arthritis (RA) is a critical pathological foundation for inducing articular injury. The janus kinase and signal transducer and activator of transcription (Jak-STAT) pathway plays a critical role in synovial membrane proliferation induced by platelet-derived growth factor (PDGF). To explore the anti-cell proliferation mechanism of curcumol, a pure monomer extracted from Chinese medical plant zedoary rhizome, the changes of Jak2-STAT1/3 signal pathway-related molecules in synoviocytes were observed in vitro. In this study, the fibroblast-like synoviocytes (FLS) in patients with RA were collected and cultured. The following parameters were measured: cell proliferation (WST-1 assay), cell cycles (fluorescence-activated cell sorting, FACS), STAT1 and STAT3 activities (electrophoretic mobility shift assay, EMSA), and the protein expressions of phosphorylated Jak2, STAT1, and STAT3 (Western blot). It was shown that curcumol could inhibit the RA-FLS proliferation and DNA synthesis induced by PDGF-BB in a dose-dependent manner in vitro. The transcription factors activities of STAT1 and STAT3 were obviously elevated after PDGF-BB stimulation (P < 0.05). Super-shift experiments identified the STAT1 or STAT3 proteins in the complex. Furthermore, the different concentration curcumol could downregulate the DNA binding activities of STAT1 and STAT3 (P < 0.05) and inhibit the phosphorylation of Jak2 while it had no effect on the protein expressions of STAT1 and STAT3. Positive correlations were found between changes of cell proliferation and DNA-binding activities of STAT1 and STAT3, respectively (P < 0.01). In conclusion, curcumol might suppress the FLS proliferation and DNA synthesis induced by PDGF-BB through attenuating Jak2 phosphorylation, downregulating STAT1 and STAT3 DNA-binding activities, which could provide theoretical foundation for clinical treatment of RA.

Citing Articles

Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure-activity relationships, and potential applications.

Zhai S, Wang R, Wang J, Xu X, Niu L, Guo M Inflammopharmacology. 2024; 32(3):1659-1704.

PMID: 38520574 DOI: 10.1007/s10787-024-01447-6.


Transgenic PDGF-BB sericin hydrogel potentiates bone regeneration of BMP9-stimulated mesenchymal stem cells through a crosstalk of the Smad-STAT pathways.

Zhang H, Li F, Wang F, Wang H, He T, Reid R Regen Biomater. 2023; 10:rbac095.

PMID: 36683747 PMC: 9847547. DOI: 10.1093/rb/rbac095.


Herbal Formula Longteng Decoction Promotes the Regression of Synovial Inflammation in Collagen-Induced Arthritis Mice by Regulating Type 2 Innate Lymphocytes.

Zhang H, Liu J, Zhang P, Li D, Feng G, Huandike M Front Pharmacol. 2022; 12:778845.

PMID: 35002715 PMC: 8735860. DOI: 10.3389/fphar.2021.778845.


Curcumol may alleviate psoriasis-like inflammation by inhibiting keratinocyte proliferation and inflammatory gene expression via JAK1/STAT3 signaling.

Lv M, Shao J, Jiang F, Liu J Aging (Albany NY). 2021; 13(14):18392-18403.

PMID: 34314383 PMC: 8351666. DOI: 10.18632/aging.203287.


Curcumol: From Plant Roots to Cancer Roots.

Wei W, Rasul A, Sadiqa A, Sarfraz I, Hussain G, Nageen B Int J Biol Sci. 2019; 15(8):1600-1609.

PMID: 31360103 PMC: 6643219. DOI: 10.7150/ijbs.34716.


References
1.
Ghoreschi K, Laurence A, OShea J . Janus kinases in immune cell signaling. Immunol Rev. 2009; 228(1):273-87. PMC: 2782696. DOI: 10.1111/j.1600-065X.2008.00754.x. View

2.
Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim H, Yoshihiro A . Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha,beta-unsaturated carbonyl group is a prerequisite. Carcinogenesis. 2002; 23(5):795-802. DOI: 10.1093/carcin/23.5.795. View

3.
George D . Platelet-derived growth factor receptors: a therapeutic target in solid tumors. Semin Oncol. 2001; 28(5 Suppl 17):27-33. View

4.
van der Pouw Kraan T, van Gaalen F, Kasperkovitz P, Verbeet N, Smeets T, Kraan M . Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 2003; 48(8):2132-45. DOI: 10.1002/art.11096. View

5.
Firestein G, Manning A . Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 1999; 42(4):609-21. DOI: 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I. View